NIMS clinical trials: 90% completed in first phase - Tv9
Fri, Jul 31, 2020, 02:44 PM
Hyderabad’s NIMS, which began clinical trials of the COVID vaccine, has been showing promising results. In the first phase, the clinical trial process has been completed on 90% of people who came forward voluntarily. Another ten persons are going to face the trials. The screening process has already begun on these ten persons.
Reports suggest that a vaccine, developed by Bharat Biotic, has been administered to 50 healthy volunteers, showing good results. NIMS doctors said there were no side effects observed so far and added that they have been monitoring them continuously. The first phase is learned to have completed successfully.